MAKALELER & KİTAP BÖLÜMLERİ

2015

  1. Cincin ZB, Unlu M, Kıran B, Bireller ES, Baran Y, Cakmakoglu B*. Apoptotic Effects of Quercitrin in DLD-1 Colon Cancer Cell Lines. Pathology and Oncology Research, 2015: 21; 333–338.
  2. Tufekçi O, Yandim MK, Oren H, Irken G, Baran Y. Targeting FOXM1 Transcription Factor In T-Cell Acute Lymphoblastic Leukemia. Leukemia Research, 2015: 39(3); 342-347.
  3. Baran Y. Kanserde İlaç Dirençliliği. Günce, Türkiye Bilimler Akademisi Dergisi, 2015; 48: 67-70.
  4. Aktar T, Chen J, Ettelaie R, Holmes M. Tactile sensitivity and capability of soft-solid texture discrimination. Journal of Texture studies, 2015 doi:10.1111/jtxs.12142.
  5. Dogan M, Aktar T, Toker OS, Tatlisu NB. Combination of the simple additive (SAW) approach and mixture design to determine optimum cocoa combination of the hot chocolate beverage. Int J Food Properties, 2015:18(8);1677-1692.
  6. Aktar T, Chen J, Ettelaie R, Holmes M. Evaluation of the sensory correlation between touch sensitivity and the capacity to discriminate viscosity. J Sensory Studies, 2015 doi:10.1111/joss.12141
  7. Gokbulut AA, Baran Y. A Novel Natural Product, KL-21, Inhibits Proliferation and Induces Apoptosis in Chronic Lymphocytic Leukemia Cells. Basım Aşamasında, 2015, Hematology.
  8. Katgı A, Sevindik OG, Gokbulut AA, Ozsan HG, Yuksel F, Solmaz SM, Alacacıoglu I, Ozcan MA, Demirkan F, Baran Y, Piskin O.  Nilotinib Does Not Alter the Secretory Funcions of Carotid Artery Endothelıal Cells in a Prothrombotic or Antithrombotic Fashion. Basım Aşamasında, 2015, Clinical and Applied Thrombosis/Hemostasis.
  9. Kartal Yandım M, Adan Gokbulut A, Baran Y. Molecular Mechanisms of Drug Resistance and its Reversal in Cancer. Revizyonda, 2015, Critical Reviews in Bitoechnology.
  10. Cincin ZB, Unlu M, Kiran B, Bireller ES, Kiraz Y, Baran Y, Cakmakoglu B. Anti-proliferative, apoptotic and signal transduction effects of hesperidin in non-small cell lung cancer cells. Basım Aşamasında, 2015, Cellular Oncology.
  11. Mutlu P, Kiraz Y, Gündüz U, BaranY. An Update On Molecular Bıology And Drug Resıstance Mechanısms Of Multıple Myeloma, Basım Aşamasında, 2015, Critical Reviews in Biotechnology.
  12. Adan A, Baran Y. The Pleiotropic Effects of Fisetin and Hesperetin on Human Acute Promyelocytic Leukemia Cells Are Mediated through Apoptosis, Cell Cycle Arrest and Alterations in Signaling Networks. Basım Aşamasında, 2015, Tumor Biology.
  13. Kaymaz BT, Günel NS, Ceyhan M, Çetintaş VB, Özel B, Yandım MK, Kıpçak S, Aktan Ç, Gökbulut AA, Baran Y, Can BK. Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted Bhsa-miR-2278 as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A. Basım Aşamasında, 2015, Tumor Biology.
  14. Yandim MK, Ceylan C, Elmas E, Baran Y. A Comparison of Macromolecular Changes in Imatinib-Sensitive and -Resistant K562 Cells Exposed to Ponatinib by Molecular Techniques and Fourier Transform Infrared Spectroscopy. Basım Aşamasında, 2015, Tumor Biology.
  15. Aktar, T., Chen, J., Ettelaie, R., & Holmes, M., Tactile sensitivity and the capability of soft-solid texture discrimination. JOURNAL OF TEXTURE STUDIES, 46(6), 429-439, 2015.

  16. Aktar, T., Chen, J., Ettelaie, R., &Holmes, M., Evaluation of the Sensory Correlation between Touch Sensitivity and the Capacity to Discriminate Viscosity: Touch Sensation and Viscosity Discrimination. JOURNAL OF SENSORY STUDIES, 30(2), 98-107, 2015.

  17. Dogan, M., Aslan, D., Aktar, T., Göksel Saraç, M., A Methodology to Evaluate the Sensory Properties of Instant Hot Chocolate Beverage with Different Fat Content: Multi-Criteria Decision Making Techniques Approach. EUROPEAN FOOD RESEARCH and TECHNOLOGY, in press.

 

ULUSLARARSI KONGRELERDE SUNULAN BİLDİRİLER

 

2015

  1. Yandım MK, Kozanoglu I, Ozdogu H, Piskin O, Ozcan MA, Saydam G, Sahin F, Ural AU, Unal A, Baran Y. Correlations Between Expression Levels of Bioactive Sphingolipid Genes and Drug-Ssensitivity and –Resistance in Chronic Myeloid Leukemia (CML) Patients. Uluslararası Seramid Konferansı & Sfingolipid Kulüp Ortak Toplantısı, 6-10 Mayıs 2015, Çeşme, Türkiye.
  2. Kartal Yandım M, Elmas E, Ceylan C, Baran Y. Antiproliferative and Apoptotic Effects of Ponatinib and its Effects on Macromolecular Changes in Imatinib-Sensitive and –Resistant Chronic Myeloid Leukemia (CML) Cell Lines: A Mechanistic Approach. 20. Avrupa Hematoloji Derneği Kongresi, 11-14 Haziran 2015, Viyana, Avusturya.
  3. Yandım MK, Kozanoglu I, Ozdogu H, Piskin O, Ozcan MA, Saydam G, Sahin F, Ural AU, Unal A, Baran Y. Discovering Alternative Targets in Chronic Myeloid Leukemia (CML): Determination of Expression Levels of Bioactive Sphingolipid Genes in Newly Diagnosed and Drug-Resistant CML Patients. 20. Avrupa Hematoloji Derneği Kongresi, 11-14 Haziran 2015, Viyana, Avusturya.
  4. Gokbulut Adan A, Baran Y. Therapeutic Potential of Fisetin and Identification of Its Mechanisms in Action in Chronic Myeloid Leukemia and  Acute Promyelocytic Leukemia Cells. 40. FEBS Kongresi & Genç Bilim İnsanı Forumu, 2-4 Temmus 2015, Berlin, Almanya.
  5. Gokbulut Adan A, Baran Y. Therapeutic Potential of Fisetin and Identification of Its Mechanisms in Action in Chronic Myeloid Leukemia and  Acute Promyelocytic Leukemia Cells.  40. FEBS Kongresi, 2-4 Temmus 2015, Berlin, Almanya.
  6. Gokbulut Adan A, Ogretmen B, Baran Y. Overcoming nilotinib resistance by specific inhibition of sphingosine-1-phosphate receptor 2/gq/phospholipase c axis in chronic myeloid leukemia. Uluslararası Seramid Konferansı & Sfingolipid Kulüp Ortak Toplantısı, 6-10 Mayıs 2015, Çeşme, Türkiye.
  7. Gokbulut Adan A, Baran Y.  A genome-wide analyses of differentially expressed genes and related networks affected by fisetin and hesperetin in chronic myeloid leukemia cells. 20. Avrupa Hematoloji Derneği Kongresi, 11-14 Haziran 2015, Viyana, Avusturya.
  8. Gokbulut Adan A, Ogretmen B, Baran Y. Sphingosine-1-phosphate receptor 2/gq/phospholipase c axis is a novel mechanism to overcome nilotinib resistance in t315i mutation expressing 32dcl3 murine cells. 20. Avrupa Hematoloji Derneği Kongresi, 11-14 Haziran 2015, Viyana, Avusturya.
  9. Gokbulut Adan A, Baran Y. The microarray gene profiling analysis of acute promyelocytic leukemia cells in response to fisetin and hesperetin. 20. Avrupa Hematoloji Derneği Kongresi, 11-14 Haziran 2015, Viyana, Avusturya.
  10. Cincin ZB, Kiraz Y, Kıran B, Baran Y, Cakmakoglu B. Molecular mechanisms of quercitrin-induced apoptosis in ECC-1 endometrial cancer cell lines. 5.Uluslararası Moleküler Tıp Kongresi,  20-22 Mayıs 2015, İzmir.
  11. Rencuzuoglu C, Cincin ZB, Kiraz Y, Baran Y, Cakmakoglu B. Investigation of potential anticarcinogenic effects by corilagin in lung cancer cells. 5.Uluslararası Moleküler Tıp Kongresi,  20-22 Mayıs 2015, İzmir.
  12. Attar R, Cincin ZB, Bireller ES, Kiraz Y, Baran Y, Cakmakoglu B Investigation of potential anticarcinogenic effects by corilagin in SKOV-3 ovarian cell line carcinoma. 5.Uluslararası Moleküler Tıp Kongresi,  20-22 Mayıs 2015, İzmir.
  13. Cincin ZB, Kiraz Y, Kıran B, Baran Y, Cakmakoglu B. Anti-proliferative, apoptotic and signal transduction effects of hesperidin in ECC-1 endometrial cancer cells. 5.Uluslararası Moleküler Tıp Kongresi,  20-22 Mayıs 2015, İzmir.
  14. Kiraz Y, Saydam G, SAhin F, Kozanoglu I, Ozdogu H, Piskin O, Ozcan MA, Avcu F, Ural AU, Unal A, Baran Y. Expression levels of Jak/STAT signaling genes in newly diagnosed drug sensitive and resistant chronic myeloid leukemia patients. 20. Avrupa Hematoloji Derneği Kongresi, 11-14 Haziran 2015, Viyana, Avusturya.
  15. Kacı N, Kiraz Y, Baran Y. Synergistic apoptotic effects of bortezomib and methylstat on different multiple myeloma cell lines. 20. Avrupa Hematoloji Derneği Kongresi, 11-14 Haziran 2015, Viyana, Avusturya.
  16. Baran Y, Kiraz Y, Adan A. Multidrug resistance mechanisms in leukemias. Biyotıbbın Geleceği Kongresi, 2-7 Eylül 2015, Russky Adası, Vladivostok, Rusya.
  17. Baran Y. Molecular Mechanisms of Drug Resistance in cancer. Annual General Meeting of The World Academy of Sciences, 18-22 November 2015, Vienna, Austria.
  18. Kiraz Y, Adan A, Baran Y. Multidrug Resistance Mechanisms in Hematological Malignancies. TWAS Regional Office for Central & South Asia (TWAS-ROCASA), At: Jawaharlal Nehru Centre for Advanced Scientific Research, 21-22 December 2015, Bangalure, India.

 

ULUSAL KONGRELERDE SUNULAN BİLDİRİLER

2015

  1. Yandım MK, Kozanoglu I, Ozdogu H, Piskin O, Ozcan MA, Saydam G, Sahin F, Ural AU, Unal A, Baran Y. Kronik Miyeloid Lösemi (KML)’de Yeni Hedef Arayışları: Yeni Tanılı ve Tirozin Kinaz İnhibitörlerine (TKİ) Dirençli Hastalarda Biyoaktif Sfingolipid Genlerinin Ekspresyon Düzeylerinin Belirlenmesi. Ege Hematoloji Onkoloji Kongresi, 13-15 Mart 2015, Çeşme.
  2. Kiraz Y, Saydam G, SAhin F, Kozanoglu I, Ozdogu H, Piskin O, Ozcan MA, Avcu F, Ural AU, Unal A, Baran Y. Expression levels of Jak/STAT signaling genes in newly diagnosed drug sensitive and resistant chronic myeloid leukemia patients. Ege Hematoloji Onkoloji Kongresi, 13-15 Mart 2015, Çeşme.
  3. Gokbulut Adan A, Ogretmen B, Baran Y. Identification and targeting of sphingosine-1-phosphate receptor 2/PP2A signal axis to reverse nilotinib resistance. Ege Hematoloji Onkoloji Kongresi, 13-15 Mart 2015, Çeşme.
  4. Kiraz Y, Neergheen-Bhujun VS, Baran Y. Punica granatum Ekstresinin Multiple Myeloma Hücreleri Üzerine Apoptotik Etkileri. Ege Hematoloji Onkoloji Kongresi, 13-15 Mart 2015, İzmir, Türkiye.
  5. Apohan E, Yılmaz U, Yılmaz O, Serindag A, Yesilada O, Kucukbay H, Kaya E, Baran Y, Kiraz Y. The cytotoxic effects of new benzimidiasol metal complex compounds on chronic myeloid leukemia cells. II. Uluslararası Katılımlı Deneysel Hematoloji Kongresi, 17-19 Nisan 2015, Kayseri.
  6. Öztürk SA, Erçetin AP, Kartal Yandım M, Kiraz Y, Aktaş S, Dursun D, Baran Y, Özcan MA. Production of chronic myeloid leukemia stem cells. II. Uluslararası Katılımlı Deneysel Hematoloji Kongresi, 17-19 Nisan 2015, Kayseri.
  7. Kiraz Y, Saydam G, SAhin F, Kozanoglu I, Ozdogu H, Piskin O, Ozcan MA, Avcu F, Ural AU, Unal A, Baran Y. A new molecular view on TKI resistance: Jak/STAT signaling in newly diagnosed, sensitive and resistance CML patients. II. Uluslararası Katılımlı Deneysel Hematoloji Kongresi, 17-19 Nisan 2015, Kayseri.
  8. Gokbulut Adan A, Baran Y.  Genome wide microarray based identification of genes involved in fisetin-mediated antiproliferative and apoptotic effects in chronic myeloid leukemia and acute myeloid leukemia cells. Ege Hematoloji Onkoloji Kongresi, 13-15 Mart 2015, Çeşme.
  9. Gokbulut Adan A, Baran Y.  Identification of altered genes and networks in hesperetin-treated chronic myeloid leukemia and acute myeloid leukemia cells by whole genome microarray analysis. Ege Hematoloji Onkoloji Kongresi, 13-15 Mart 2015, Çeşme.
  10. Gokbulut Adan A, Baran Y.   Whole-genome microarray anaylsis to identifiy signaling pathways involved in hesperetin-mediated apoptosis in chronic myeloid and acute myeloid leukemia cells. II. Uluslararası Katılımlı Deneysel Hematoloji Kongresi, 17-19 Nisan 2015, Kayseri.
  11. Gokbulut Adan A, Baran Y.  Identification of genes and genetic networks modulated by fisetin in in chronic myeloid and acute myeloid leukemia cells by whole-genome microarray analysis. II. Uluslararası Katılımlı Deneysel Hematoloji Kongresi, 17-19 Nisan 2015, Kayseri.
  12. Kacı FN, Baran Y, Engür S. Bortezomib ve Metilstatın Farklı Multipl Myeloma Hücreleri Üzerindeki Sinerjik Apoptotik Etkileri. II. Uluslararası Katılımlı Deneysel Hematoloji Kongresi, 17-19 Nisan 2015, Kayseri.